US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 14.990
  • +0.880+6.24%
Close Dec 20 16:00 ET
  • 15.110
  • +0.120+0.80%
Post 20:01 ET
1.75BMarket Cap-8.98P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
17.44%44.76M
494.57%30.86M
1,682.42%49.57M
1,517.09%59.61M
356.81%13.53M
5,156.41%38.11M
5.19M
2.78M
3.69M
2.96M
Operating revenue
451.92%44.76M
546.92%30.86M
675.58%21.57M
691.81%29.19M
356.81%13.53M
1,018.48%8.11M
--4.77M
--2.78M
--3.69M
--2.96M
Cost of revenue
365.57%5.5M
346.39%3.46M
315.84%3.26M
561.41%4.99M
363.09%2.25M
339.41%1.18M
776K
783K
754K
485K
Gross profit
6.30%39.25M
520.62%27.39M
2,217.97%46.31M
1,762.86%54.62M
355.57%11.28M
7,998.03%36.93M
4.41M
2M
2.93M
2.48M
Operating expense
6.08%78.32M
8.84%77.47M
-0.42%77.94M
-2.90%295.72M
2.18%72.45M
-29.82%73.83M
8.13%71.18M
24.96%78.26M
47.47%304.56M
-0.54%70.9M
Selling and administrative expenses
23.58%58.82M
26.58%58.17M
27.67%54.79M
51.60%185.15M
31.47%48.67M
34.17%47.6M
66.38%45.96M
95.03%42.92M
100.30%122.12M
97.69%37.02M
Research and development costs
-25.67%19.5M
-23.48%19.3M
-34.53%23.14M
-39.39%110.58M
-29.82%23.78M
-62.38%26.24M
-33.99%25.22M
-12.99%35.35M
25.33%182.44M
-35.54%33.88M
Operating profit
-5.86%-39.07M
24.99%-50.08M
58.54%-31.62M
20.07%-241.1M
10.60%-61.17M
64.77%-36.9M
-1.42%-66.76M
-21.77%-76.27M
-46.05%-301.63M
4.01%-68.42M
Net non-operating interest income expense
11.99%-6.65M
-1.84%-7.48M
-6.22%-7.48M
-89.83%-29.71M
-12.25%-7.76M
-54.30%-7.56M
-267.45%-7.35M
-283.13%-7.04M
-15.65M
-6.92M
Non-operating interest expense
-11.99%6.65M
1.84%7.48M
6.22%7.48M
89.83%29.71M
12.25%7.76M
54.30%7.56M
267.45%7.35M
283.13%7.04M
--15.65M
--6.92M
Other net income (expense)
53.69%4.18M
67.54%5.23M
26.10%4.04M
102.47%11.79M
-19.52%2.67M
40.40%2.72M
641.33%3.12M
2,158.45%3.21M
3,264.74%5.82M
8,400.00%3.32M
Other non- operating income (expenses)
53.69%4.18M
67.54%5.23M
26.10%4.04M
102.47%11.79M
-19.52%2.67M
40.40%2.72M
641.33%3.12M
2,158.45%3.21M
3,264.74%5.82M
8,400.00%3.32M
Income before tax
0.49%-41.54M
26.28%-52.33M
56.23%-35.06M
16.83%-259.03M
8.00%-66.26M
61.25%-41.74M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
Income tax
0
0
324K
3.11M
25K
3.02M
0
0
0
0
Net income
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
Net income continuous Operations
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
Minority interest income
Net income attributable to the parent company
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
Basic earnings per share
54.79%-0.33
63.79%-0.42
75.57%-0.32
33.22%-3.78
38.98%-0.72
61.38%-0.73
11.45%-1.16
-3.15%-1.31
-35.41%-5.66
16.90%-1.18
Diluted earnings per share
54.79%-0.33
63.79%-0.42
75.57%-0.32
33.22%-3.78
38.98%-0.72
61.38%-0.73
11.45%-1.16
-3.15%-1.31
-35.41%-5.66
16.90%-1.18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 17.44%44.76M494.57%30.86M1,682.42%49.57M1,517.09%59.61M356.81%13.53M5,156.41%38.11M5.19M2.78M3.69M2.96M
Operating revenue 451.92%44.76M546.92%30.86M675.58%21.57M691.81%29.19M356.81%13.53M1,018.48%8.11M--4.77M--2.78M--3.69M--2.96M
Cost of revenue 365.57%5.5M346.39%3.46M315.84%3.26M561.41%4.99M363.09%2.25M339.41%1.18M776K783K754K485K
Gross profit 6.30%39.25M520.62%27.39M2,217.97%46.31M1,762.86%54.62M355.57%11.28M7,998.03%36.93M4.41M2M2.93M2.48M
Operating expense 6.08%78.32M8.84%77.47M-0.42%77.94M-2.90%295.72M2.18%72.45M-29.82%73.83M8.13%71.18M24.96%78.26M47.47%304.56M-0.54%70.9M
Selling and administrative expenses 23.58%58.82M26.58%58.17M27.67%54.79M51.60%185.15M31.47%48.67M34.17%47.6M66.38%45.96M95.03%42.92M100.30%122.12M97.69%37.02M
Research and development costs -25.67%19.5M-23.48%19.3M-34.53%23.14M-39.39%110.58M-29.82%23.78M-62.38%26.24M-33.99%25.22M-12.99%35.35M25.33%182.44M-35.54%33.88M
Operating profit -5.86%-39.07M24.99%-50.08M58.54%-31.62M20.07%-241.1M10.60%-61.17M64.77%-36.9M-1.42%-66.76M-21.77%-76.27M-46.05%-301.63M4.01%-68.42M
Net non-operating interest income expense 11.99%-6.65M-1.84%-7.48M-6.22%-7.48M-89.83%-29.71M-12.25%-7.76M-54.30%-7.56M-267.45%-7.35M-283.13%-7.04M-15.65M-6.92M
Non-operating interest expense -11.99%6.65M1.84%7.48M6.22%7.48M89.83%29.71M12.25%7.76M54.30%7.56M267.45%7.35M283.13%7.04M--15.65M--6.92M
Other net income (expense) 53.69%4.18M67.54%5.23M26.10%4.04M102.47%11.79M-19.52%2.67M40.40%2.72M641.33%3.12M2,158.45%3.21M3,264.74%5.82M8,400.00%3.32M
Other non- operating income (expenses) 53.69%4.18M67.54%5.23M26.10%4.04M102.47%11.79M-19.52%2.67M40.40%2.72M641.33%3.12M2,158.45%3.21M3,264.74%5.82M8,400.00%3.32M
Income before tax 0.49%-41.54M26.28%-52.33M56.23%-35.06M16.83%-259.03M8.00%-66.26M61.25%-41.74M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M
Income tax 00324K3.11M25K3.02M0000
Net income 7.21%-41.54M26.28%-52.33M55.83%-35.38M15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M
Net income continuous Operations 7.21%-41.54M26.28%-52.33M55.83%-35.38M15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M
Minority interest income
Net income attributable to the parent company 7.21%-41.54M26.28%-52.33M55.83%-35.38M15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.21%-41.54M26.28%-52.33M55.83%-35.38M15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M
Basic earnings per share 54.79%-0.3363.79%-0.4275.57%-0.3233.22%-3.7838.98%-0.7261.38%-0.7311.45%-1.16-3.15%-1.31-35.41%-5.6616.90%-1.18
Diluted earnings per share 54.79%-0.3363.79%-0.4275.57%-0.3233.22%-3.7838.98%-0.7261.38%-0.7311.45%-1.16-3.15%-1.31-35.41%-5.6616.90%-1.18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List